Webb22 sep. 2024 · NiKang Therapeutics, Inc., a biotech company, announced the completion of Series B financing for $50 million led by RTW Investments, LP with additional support from new investors including Lilly Asia Ventures, Casdin Capital, HBM Healthcare Investments, Matrix Partners China and Octagon Capital. Webb4 dec. 2024 · NiKang Therapeutics Comparisons Description Primary Industry HQ Location Employees Total Raised Post Valuation Last Financing Details Operator of a biotechnology company intended to discover and develop innovative small molecule oncology medicines. The c Drug Discovery Wilmington, DE 34 As of 2024 00000 0000 …
NIKANG THERAPEUTICS, INC. :: California (US) :: OpenCorporates
Webb3 maj 2024 · NiKang Therapeutics Inc., a clinical-stage biotech company focused on developing small molecule oncology medicines to help patients with unmet medical needs and Hansoh Pharmaceutical Group Company Limited, a China and US-based leading biopharmaceutical company, announced a collaboration and license agreement for the … Webb14 sep. 2024 · NiKang Therapeutics Inc. +1 908-399-4518 email us here. More From This Source NiKang Therapeutics Appoints Kelsey Chen, Ph.D., MBA, as Chief … sanchon brotaufstrich
Venture capital and emerging companies in United States Law …
Webb24 apr. 2024 · NiKang Therapeutics公司是一家总部位于美国特拉华州威明顿市的早期生物医药公司,致力于发现和开发创新性小分子抗肿瘤药物,以满足临床未竟的需求。 公司的靶点选择以疾病生物学和分子通道为驱动,开发策略以靶点结构生物学和基于结构的药物设 … WebbAt NiKang Therapeutics Inc (“NiKang”), we take pride in cultivating an environment that provides intellectual challenges and professional growth. Webb3 maj 2024 · WILMINGTON, Del.--(BUSINESS WIRE)--NiKang Therapeutics Inc. (“NiKang”), a clinical stage biotech company focused on developing innovative small … sanchovies twitch